Denali Therapeutics Announces First Patient Dosed in Phase 1b Study of DNL201 for Parkinson’s Disease
CENTOGENE and Denali Therapeutics Announce Strategic Collaboration to Recruit LRRK2 Patients for Clinical Trials
Video - CEO Clips: Blue Jay Gold: Why Are District-Scale Gold Projects Attracting Investor Attention?
Video - CEO Clips: EraNova Metals Advances Critical Mineral and Polymetallic Opportunities in British Columbia